Brief: Galera Therapeutics Receives Letter From Nasdaq Indicating That Co Has Not Regained Compliance With Listing Rules

Obsidian Therapeutics

27/03/2024 11:43

March 27 (Reuters) - Galera Therapeutics Inc  GRTX.O :
    * GALERA THERAPEUTICS - ON MARCH 26 RECEIVED LETTER FROM
NASDAQ
STAFF INDICATING THAT CO HAS NOT REGAINED COMPLIANCE WITH MVPHS
    * GALERA THERAPEUTICS - INTENDS TO REQUEST HEARING BEFORE A
PANEL
AT WHICH IT WILL REQUEST CONTINUED LISTING PENDING ITS RETURN TO
COMPLIANCE

Source text for Eikon:  ID:n0001193125-24-078226 
Further company coverage:  GRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))